Related references
Note: Only part of the references are listed.Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea
Ciaran P. Kelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
Natural Clostridioides difficile Toxin Immunization in Colonized Infants
Larry K. Kociolek et al.
CLINICAL INFECTIOUS DISEASES (2020)
Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection
Nicole C. White et al.
CLINICAL INFECTIOUS DISEASES (2020)
Trends in US Burden of Clostridioides difficile Infection and Outcomes
Alice Y. Guh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention
Sara Lynn Revolinski et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy
William D. Rees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients
Michelle Hughes et al.
INFLAMMATORY BOWEL DISEASES (2016)
Recurrent Clostridium difficile infection: From colonization to cure
Kelsey Shields et al.
ANAEROBE (2015)
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool
Linan Song et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis
Maria J. G. T. Vehreschild et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
S. B. Debast et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Clostridium difficile Infection after Adult Autologous Stem Cell Transplantation: A Multicenter Study of Epidemiology and Risk Factors
Carolyn D. Alonso et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Clostridium difficile Carriage and Serum Antitoxin Responses in Children with Inflammatory Bowel Disease
Suchitra K. Hourigan et al.
INFLAMMATORY BOWEL DISEASES (2013)
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Amit S. Chitnis et al.
JAMA INTERNAL MEDICINE (2013)
IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile Infection
M. Wullt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients
Carolyn D. Alonso et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis
Muhammad Ali et al.
LIVER TRANSPLANTATION (2012)
Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database
C. Pant et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation
Teena Chopra et al.
CLINICAL TRANSPLANTATION (2011)
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
Brett A. Leav et al.
VACCINE (2010)
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
Jaime Belmares et al.
JOURNAL OF INFECTION (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea
SS Johal et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Human antibody response to surface layer proteins in Clostridium difficile infection
D Drudy et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
L Kyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
